These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery. Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Cheng L; Bostwick DG J Urol; 1999 Apr; 161(4):1233-7. PubMed ID: 10081876 [TBL] [Abstract][Full Text] [Related]
6. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707 [TBL] [Abstract][Full Text] [Related]
7. Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes. Shariat SF; Roudier MP; Wilcox GE; Kattan MW; Scardino PT; Vessella RL; Erdamar S; Nguyen C; Wheeler TM; Slawin KM Cancer Res; 2003 Aug; 63(15):4662-70. PubMed ID: 12907647 [TBL] [Abstract][Full Text] [Related]
8. Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer. Haese A; Becker C; Noldus J; Graefen M; Huland E; Huland H; Lilja H J Urol; 2000 May; 163(5):1491-7. PubMed ID: 10751864 [TBL] [Abstract][Full Text] [Related]
9. Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy. Shariat SF; Gottenger E; Nguyen C; Song W; Kattan MW; Andenoro J; Wheeler TM; Spencer DM; Slawin KM Cancer Res; 2002 Oct; 62(20):5974-9. PubMed ID: 12384565 [TBL] [Abstract][Full Text] [Related]
10. Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections. Siivola P; Pettersson K; Piironen T; Lövgren T; Lilja H; Bjartell A Urology; 2000 Oct; 56(4):682-8. PubMed ID: 11018639 [TBL] [Abstract][Full Text] [Related]
11. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity. Finlay JA; Evans CL; Day JR; Payne JK; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Wolfert RL; Rittenhouse HG Urology; 1998 May; 51(5):804-9. PubMed ID: 9610595 [TBL] [Abstract][Full Text] [Related]
12. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL. Kwiatkowski MK; Recker F; Piironen T; Pettersson K; Otto T; Wernli M; Tscholl R Urology; 1998 Sep; 52(3):360-5. PubMed ID: 9730444 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients. Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910 [TBL] [Abstract][Full Text] [Related]
14. Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels. Charlesworth MC; Young CY; Klee GG; Saedi MS; Mikolajczyk SD; Finlay JA; Tindall DJ Urology; 1997 Mar; 49(3):487-93. PubMed ID: 9123724 [TBL] [Abstract][Full Text] [Related]
15. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Rittenhouse HG; Finlay JA; Mikolajczyk SD; Partin AW Crit Rev Clin Lab Sci; 1998 Aug; 35(4):275-368. PubMed ID: 9759557 [TBL] [Abstract][Full Text] [Related]
16. Expression of human glandular kallikrein, hK2, in mammalian cells. Kumar A; Goel AS; Hill TM; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Saedi MS Cancer Res; 1996 Dec; 56(23):5397-402. PubMed ID: 8968092 [TBL] [Abstract][Full Text] [Related]
17. Different proportions of various prostate-specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells. Kumar A; Mikolajczyk SD; Hill TM; Millar LS; Saedi MS Prostate; 2000 Aug; 44(3):248-54. PubMed ID: 10906742 [TBL] [Abstract][Full Text] [Related]
18. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate. Sheridan T; Herawi M; Epstein JI; Illei PB Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190 [TBL] [Abstract][Full Text] [Related]
19. Assessment of optimal target genes for detecting micrometastases in pelvic lymph nodes in patients with prostate cancer undergoing radical prostatectomy by real-time reverse transcriptase-polymerase chain reaction. Kusuda Y; Miyake H; Kurahashi T; Fujisawa M Urol Oncol; 2013 Jul; 31(5):615-21. PubMed ID: 21600799 [TBL] [Abstract][Full Text] [Related]
20. Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen. Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Huber A; Lümmen G; Tscholl R Urology; 2000 Apr; 55(4):481-5. PubMed ID: 10736487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]